{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "3dc1971d-a67e-47eb-a6b9-aa7d4338705a",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-07-11T18:33:55.435853Z",
     "iopub.status.busy": "2025-07-11T18:33:55.435524Z",
     "iopub.status.idle": "2025-07-11T18:33:55.849855Z",
     "shell.execute_reply": "2025-07-11T18:33:55.849535Z",
     "shell.execute_reply.started": "2025-07-11T18:33:55.435829Z"
    }
   },
   "outputs": [],
   "source": [
    "import requests\n",
    "from bs4 import BeautifulSoup\n",
    "from bs4.element import Tag\n",
    "from urllib.parse import urljoin\n",
    "import pandas as pd\n",
    "from firecrawl import FirecrawlApp\n",
    "import os\n",
    "\n",
    "# It's recommended to set the API key as an environment variable\n",
    "# For this example, we'll use the provided key directly, but this is not best practice\n",
    "FIRECRAWL_API_KEY = os.getenv('FIRECRAWL_API_KEY')\n",
    "# Initialize FirecrawlApp\n",
    "# It will automatically use the FIRECRAWL_API_KEY environment variable if set,\n",
    "# otherwise you can pass it as an argument: FirecrawlApp(api_key=\"YOUR_API_KEY\")\n",
    "app = FirecrawlApp(api_key=FIRECRAWL_API_KEY)\n",
    "\n",
    "\n",
    "BASE_URL_DRUG_SAFETY = \"https://www.gov.uk/drug-safety-update\"\n",
    "\n",
    "def scrape_detailed_alert_info_with_firecrawl(url):\n",
    "    \"\"\"\n",
    "    Scrapes a detailed alert page using Firecrawl to get markdown content.\n",
    "    \"\"\"\n",
    "    try:\n",
    "        scraped_data = app.scrape_url(url, params={'pageOptions': {'onlyMainContent': True}})\n",
    "        if scraped_data and 'markdown' in scraped_data:\n",
    "            # The detailed title is usually the first line of the markdown\n",
    "            lines = scraped_data['markdown'].split('\\n')\n",
    "            detailed_title = lines[0].strip('# ') if lines else \"\"\n",
    "            detailed_content = scraped_data['markdown']\n",
    "            return {'detailed_title': detailed_title, 'detailed_content': detailed_content}\n",
    "        else:\n",
    "            print(f\"Firecrawl failed to return markdown for {url}\")\n",
    "            return {'detailed_title': None, 'detailed_content': None}\n",
    "    except Exception as e:\n",
    "        print(f\"An error occurred while scraping with Firecrawl for {url}: {e}\")\n",
    "        return {'detailed_title': None, 'detailed_content': None}\n",
    "\n",
    "def scrape_drug_safety_updates():\n",
    "    \"\"\"\n",
    "    Scrapes the list of drug safety updates, including dates, and then each linked page for detailed info using Firecrawl.\n",
    "    Returns a pandas DataFrame.\n",
    "    \"\"\"\n",
    "    listing_data = []\n",
    "\n",
    "    print(f\"Scraping listing page with requests: {BASE_URL_DRUG_SAFETY}\")\n",
    "    response = requests.get(BASE_URL_DRUG_SAFETY)\n",
    "    response.raise_for_status()\n",
    "    soup = BeautifulSoup(response.content, 'html.parser')\n",
    "\n",
    "    alerts = []\n",
    "    for li in soup.select('ul.gem-c-document-list li'):\n",
    "        link = li.find('a')\n",
    "        # Find the date text directly within the list item\n",
    "        # Only proceed if a link is found\n",
    "        if link and isinstance(link, Tag): # Ensure link is a Tag object\n",
    "            date_text = li.get_text(strip=True).replace(link.get_text(strip=True), '').strip()\n",
    "\n",
    "            if date_text:\n",
    "                title = link.get_text(strip=True)\n",
    "                href_attr = link.get('href') # Use .get() to safely retrieve attribute\n",
    "                if href_attr and isinstance(href_attr, str): # Ensure href_attr is a string\n",
    "                    full_url = urljoin(BASE_URL_DRUG_SAFETY, href_attr)\n",
    "\n",
    "                    # Assuming the date format is consistent, you might need to adjust this\n",
    "                    # if the format varies.\n",
    "                    published_date = pd.to_datetime(date_text, errors='coerce')\n",
    "\n",
    "                    alerts.append({'publish_date': published_date, 'title': title, 'url': full_url})\n",
    "    listing_data = alerts\n",
    "\n",
    "    print(listing_data)\n",
    "    df = pd.DataFrame(listing_data)\n",
    "    return df\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "a841976a-3347-4b33-a086-93e860f8e564",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-07-11T18:34:10.493203Z",
     "iopub.status.busy": "2025-07-11T18:34:10.492608Z",
     "iopub.status.idle": "2025-07-11T18:34:10.815881Z",
     "shell.execute_reply": "2025-07-11T18:34:10.815565Z",
     "shell.execute_reply.started": "2025-07-11T18:34:10.493180Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Scraping listing page with requests: https://www.gov.uk/drug-safety-update\n",
      "[{'publish_date': NaT, 'title': 'Abrysvo▼ (Pfizer RSV vaccine) and Arexvy▼ (GSK RSV vaccine): be alert to a small risk of Guillain-Barré syndrome following vaccination in older adults', 'url': 'https://www.gov.uk/drug-safety-update/abrysvov-pfizer-rsv-vaccine-and-arexvyv-gsk-rsv-vaccine-be-alert-to-a-small-risk-of-guillain-barre-syndrome-following-vaccination-in-older-adults'}, {'publish_date': NaT, 'title': 'IXCHIQ Chikungunya vaccine: temporary suspension in people aged 65 years or older', 'url': 'https://www.gov.uk/drug-safety-update/ixchiq-chikungunya-vaccine-temporary-suspension-in-people-aged-65-years-or-older'}, {'publish_date': NaT, 'title': 'Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono or Chronosphere, Episenta, Epival, and Syonell▼): updated safety and educational materials to support patient discussion on reproductive risks', 'url': 'https://www.gov.uk/drug-safety-update/valproate-belvo-convulex-depakote-dyzantil-epilim-epilim-chrono-or-chronosphere-episenta-epival-and-syonellv-updated-safety-and-educational-materials-to-support-patient-discussion-on-reproductive-risks'}, {'publish_date': NaT, 'title': 'Thiopurines and intrahepatic cholestasis of pregnancy', 'url': 'https://www.gov.uk/drug-safety-update/thiopurines-and-intrahepatic-cholestasis-of-pregnancy'}, {'publish_date': NaT, 'title': 'Kaftrio▼ (Ivacaftor, tezacaftor, elexacaftor): risk of psychological side effects', 'url': 'https://www.gov.uk/drug-safety-update/kaftriov-ivacaftor-tezacaftor-elexacaftor-risk-of-psychological-side-effects'}, {'publish_date': NaT, 'title': 'Short-acting beta 2 agonists (SABA) (salbutamol and terbutaline): reminder of the risks from overuse in asthma and to be aware of changes in the SABA prescribing guidelines', 'url': 'https://www.gov.uk/drug-safety-update/short-acting-beta-2-agonists-saba-salbutamol-and-terbutaline-reminder-of-the-risks-from-overuse-in-asthma-and-to-be-aware-of-changes-in-the-saba-prescribing-guidelines'}, {'publish_date': NaT, 'title': 'Fezolinetant▼(Veoza): risk of liver injury; new recommendations to minimise risk', 'url': 'https://www.gov.uk/drug-safety-update/fezolinetantv-veoza-risk-of-liver-injury-new-recommendations-to-minimise-risk'}, {'publish_date': NaT, 'title': 'Prolonged-release opioids: Removal of indication for relief of post-operative pain', 'url': 'https://www.gov.uk/drug-safety-update/prolonged-release-opioids-removal-of-indication-for-relief-of-post-operative-pain'}, {'publish_date': NaT, 'title': 'Letters and medicine recalls sent to healthcare professionals in January 2025', 'url': 'https://www.gov.uk/drug-safety-update/letters-and-medicine-recalls-sent-to-healthcare-professionals-in-january-2025'}, {'publish_date': NaT, 'title': 'Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono or  Chronosphere, Episenta, Epival, and Syonell▼): review by  two specialists is required for initiating valproate but not for  male patients already taking valproate', 'url': 'https://www.gov.uk/drug-safety-update/valproate-belvo-convulex-depakote-dyzantil-epilim-epilim-chrono-or-chronosphere-episenta-epival-and-syonellv-review-by-two-specialists-is-required-for-initiating-valproate-but-not-for-male-patients-already-taking-valproate'}, {'publish_date': NaT, 'title': 'GLP-1 and dual GIP/GLP-1 receptor agonists:\\u202fpotential risk of pulmonary aspiration during general anaesthesia or deep sedation', 'url': 'https://www.gov.uk/drug-safety-update/glp-1-and-dual-gip-slash-glp-1-receptor-agonists-potential-risk-of-pulmonary-aspiration-during-general-anaesthesia-or-deep-sedation'}, {'publish_date': NaT, 'title': 'Letters and medicine recalls sent to healthcare professionals in December 2024', 'url': 'https://www.gov.uk/drug-safety-update/letters-and-medicine-recalls-sent-to-healthcare-professionals-in-december-2024'}, {'publish_date': NaT, 'title': 'Letters and medicine recalls sent to healthcare professionals in November 2024', 'url': 'https://www.gov.uk/drug-safety-update/letters-and-medicine-recalls-sent-to-healthcare-professionals-in-november-2024'}, {'publish_date': NaT, 'title': 'MedSafetyWeek November 2024: your Yellow Card report helps prevent future harm to others and improves patient safety', 'url': 'https://www.gov.uk/drug-safety-update/medsafetyweek-november-2024-your-yellow-card-report-helps-prevent-future-harm-to-others-and-improves-patient-safety'}, {'publish_date': NaT, 'title': 'Letters and medicine recalls sent to healthcare professionals in October 2024', 'url': 'https://www.gov.uk/drug-safety-update/letters-and-medicine-recalls-sent-to-healthcare-professionals-in-october-2024'}, {'publish_date': NaT, 'title': 'GLP-1 receptor agonists: reminder of the potential side effects and to be aware of the potential for misuse', 'url': 'https://www.gov.uk/drug-safety-update/glp-1-receptor-agonists-reminder-of-the-potential-side-effects-and-to-be-aware-of-the-potential-for-misuse'}, {'publish_date': NaT, 'title': 'Insulin pumps and continuous glucose monitoring (CGM) equipment: guidance for users on reporting suspected adverse incidents and safety concerns to the MHRA’s Yellow Card scheme', 'url': 'https://www.gov.uk/drug-safety-update/insulin-pumps-and-continuous-glucose-monitoring-cgm-equipment-guidance-for-users-on-reporting-suspected-adverse-incidents-and-safety-concerns-to-the-mhras-yellow-card-scheme'}, {'publish_date': NaT, 'title': 'Bromocriptine: monitor blood pressure when prescribing bromocriptine for prevention or inhibition of post-partum physiological lactation', 'url': 'https://www.gov.uk/drug-safety-update/bromocriptine-monitor-blood-pressure-when-prescribing-bromocriptine-for-prevention-or-inhibition-of-post-partum-physiological-lactation'}, {'publish_date': NaT, 'title': 'Letters and medicine recalls sent to healthcare professionals in September 2024', 'url': 'https://www.gov.uk/drug-safety-update/letters-and-medicine-recalls-sent-to-healthcare-professionals-in-september-2024'}, {'publish_date': NaT, 'title': 'Letters and medicine recalls sent to healthcare professionals in August 2024', 'url': 'https://www.gov.uk/drug-safety-update/letters-and-medicine-recalls-sent-to-healthcare-professionals-in-august-2024'}, {'publish_date': NaT, 'title': 'Valproate use in men: as a precaution, men and their partners should use effective contraception', 'url': 'https://www.gov.uk/drug-safety-update/valproate-use-in-men-as-a-precaution-men-and-their-partners-should-use-effective-contraception'}, {'publish_date': NaT, 'title': 'Yellow Card Biobank: call to contribute to study of genetic links to side effects', 'url': 'https://www.gov.uk/drug-safety-update/yellow-card-biobank-call-to-contribute-to-study-of-genetic-links-to-side-effects'}, {'publish_date': NaT, 'title': 'Letters and medicine recalls sent to healthcare professionals in July 2024', 'url': 'https://www.gov.uk/drug-safety-update/letters-and-medicine-recalls-sent-to-healthcare-professionals-in-july-2024'}, {'publish_date': NaT, 'title': 'Epimax Ointment and Epimax Paraffin-Free Ointment: reports of ocular surface toxicity and ocular chemical injury', 'url': 'https://www.gov.uk/drug-safety-update/epimax-ointment-and-epimax-paraffin-free-ointment-reports-of-ocular-surface-toxicity-and-ocular-chemical-injury'}, {'publish_date': NaT, 'title': 'Letters and medicine recalls sent to healthcare professionals in June 2024', 'url': 'https://www.gov.uk/drug-safety-update/letters-and-medicine-recalls-sent-to-healthcare-professionals-in-june-2024'}, {'publish_date': NaT, 'title': 'Topiramate (Topamax): introduction of new safety measures, including a Pregnancy Prevention Programme', 'url': 'https://www.gov.uk/drug-safety-update/topiramate-topamax-introduction-of-new-safety-measures-including-a-pregnancy-prevention-programme'}, {'publish_date': NaT, 'title': 'Warfarin: be alert to the risk of drug interactions with tramadol', 'url': 'https://www.gov.uk/drug-safety-update/warfarin-be-alert-to-the-risk-of-drug-interactions-with-tramadol'}, {'publish_date': NaT, 'title': 'Letters and medicine recalls sent to healthcare professionals in May 2024', 'url': 'https://www.gov.uk/drug-safety-update/letters-and-medicine-recalls-sent-to-healthcare-professionals-in-may-2024'}, {'publish_date': NaT, 'title': 'Topical steroids: introduction of new labelling and a reminder of the possibility of severe side effects, including Topical Steroid Withdrawal Reactions', 'url': 'https://www.gov.uk/drug-safety-update/topical-steroids-introduction-of-new-labelling-and-a-reminder-of-the-possibility-of-severe-side-effects-including-topical-steroid-withdrawal-reactions'}, {'publish_date': NaT, 'title': 'Letters and medicine recalls sent to healthcare professionals in April 2024', 'url': 'https://www.gov.uk/drug-safety-update/letters-and-medicine-recalls-sent-to-healthcare-professionals-in-april-2024'}, {'publish_date': NaT, 'title': 'Finasteride: reminder of the risk psychiatric side effects and of sexual side effects (which may persist after discontinuation of treatment)', 'url': 'https://www.gov.uk/drug-safety-update/finasteride-reminder-of-the-risk-psychiatric-side-effects-and-of-sexual-side-effects-which-may-persist-after-discontinuation-of-treatment'}, {'publish_date': NaT, 'title': 'Montelukast: reminder of the risk of neuropsychiatric reactions', 'url': 'https://www.gov.uk/drug-safety-update/montelukast-reminder-of-the-risk-of-neuropsychiatric-reactions'}, {'publish_date': NaT, 'title': 'Letters and medicine recalls sent to healthcare professionals in March 2024', 'url': 'https://www.gov.uk/drug-safety-update/letters-and-medicine-recalls-sent-to-healthcare-professionals-in-march-2024'}, {'publish_date': NaT, 'title': 'Letters and medicine recalls sent to healthcare professionals in February 2024', 'url': 'https://www.gov.uk/drug-safety-update/letters-and-medicine-recalls-sent-to-healthcare-professionals-in-february-2024'}, {'publish_date': NaT, 'title': 'Codeine linctus (codeine oral solutions): reclassification to prescription-only medicine', 'url': 'https://www.gov.uk/drug-safety-update/codeine-linctus-codeine-oral-solutions-reclassification-to-prescription-only-medicine'}, {'publish_date': NaT, 'title': 'Pseudoephedrine: very rare risk of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS)', 'url': 'https://www.gov.uk/drug-safety-update/pseudoephedrine-very-rare-risk-of-posterior-reversible-encephalopathy-syndrome-pres-and-reversible-cerebral-vasoconstriction-syndrome-rcvs'}, {'publish_date': NaT, 'title': 'Letters and medicine recalls sent to healthcare professionals in January 2024', 'url': 'https://www.gov.uk/drug-safety-update/letters-and-medicine-recalls-sent-to-healthcare-professionals-in-january-2024'}, {'publish_date': NaT, 'title': 'Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono or Chronosphere, Episenta, Epival, and Syonell▼): new safety and educational materials to support regulatory measures in men and women under 55 years of age', 'url': 'https://www.gov.uk/drug-safety-update/valproate-belvo-convulex-depakote-dyzantil-epilim-epilim-chrono-or-chronosphere-episenta-epival-and-syonellv-new-safety-and-educational-materials-to-support-regulatory-measures-in-men-and-women-under-55-years-of-age'}, {'publish_date': NaT, 'title': 'Fluoroquinolone antibiotics: must now only be prescribed when other commonly recommended antibiotics are inappropriate', 'url': 'https://www.gov.uk/drug-safety-update/fluoroquinolone-antibiotics-must-now-only-be-prescribed-when-other-commonly-recommended-antibiotics-are-inappropriate'}, {'publish_date': NaT, 'title': 'Omega-3-acid ethyl ester medicines (Omacor/Teromeg 1000mg capsules): dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or cardiovascular risk factors', 'url': 'https://www.gov.uk/drug-safety-update/omega-3-acid-ethyl-ester-medicines-omacor-slash-teromeg-1000mg-capsules-dose-dependent-increased-risk-of-atrial-fibrillation-in-patients-with-established-cardiovascular-diseases-or-cardiovascular-risk-factors'}, {'publish_date': NaT, 'title': 'Letters and medicine recalls sent to healthcare professionals in December 2023', 'url': 'https://www.gov.uk/drug-safety-update/letters-and-medicine-recalls-sent-to-healthcare-professionals-in-december-2023'}, {'publish_date': NaT, 'title': 'Aripiprazole (Abilify and generic brands): risk of pathological gambling', 'url': 'https://www.gov.uk/drug-safety-update/aripiprazole-abilify-and-generic-brands-risk-of-pathological-gambling'}, {'publish_date': NaT, 'title': 'Vitamin B12 (hydroxocobalamin, cyanocobalamin): advise patients with known cobalt allergy to be vigilant for sensitivity reactions', 'url': 'https://www.gov.uk/drug-safety-update/vitamin-b12-hydroxocobalamin-cyanocobalamin-advise-patients-with-known-cobalt-allergy-to-be-vigilant-for-sensitivity-reactions'}, {'publish_date': NaT, 'title': 'Letters and medicine recalls sent to healthcare professionals in November 2023', 'url': 'https://www.gov.uk/drug-safety-update/letters-and-medicine-recalls-sent-to-healthcare-professionals-in-november-2023'}, {'publish_date': NaT, 'title': 'Ozempic▼(semaglutide) and Saxenda (liraglutide): vigilance required due to potentially harmful falsified products', 'url': 'https://www.gov.uk/drug-safety-update/ozempicv-semaglutide-and-saxenda-liraglutide-vigilance-required-due-to-potentially-harmful-falsified-products'}, {'publish_date': NaT, 'title': 'Nirmatrelvir, ritonavir (Paxlovid▼): be alert to the risk of drug interactions with ritonavir', 'url': 'https://www.gov.uk/drug-safety-update/nirmatrelvir-ritonavir-paxlovidv-be-alert-to-the-risk-of-drug-interactions-with-ritonavir'}, {'publish_date': NaT, 'title': 'E-cigarette use or vaping: reminder to remain vigilant for suspected adverse reactions and safety concerns and report them to the Yellow Card scheme', 'url': 'https://www.gov.uk/drug-safety-update/e-cigarette-use-or-vaping-reminder-to-remain-vigilant-for-suspected-adverse-reactions-and-safety-concerns-and-report-them-to-the-yellow-card-scheme'}, {'publish_date': NaT, 'title': 'Letters and medicine recalls sent to healthcare professionals in October 2023', 'url': 'https://www.gov.uk/drug-safety-update/letters-and-medicine-recalls-sent-to-healthcare-professionals-in-october-2023'}, {'publish_date': NaT, 'title': 'Isotretinoin (Roaccutane▼): introduction of new safety measures, including additional oversight of the initiation of treatment for patients under 18 years of age', 'url': 'https://www.gov.uk/drug-safety-update/isotretinoin-roaccutanev-introduction-of-new-safety-measures-including-additional-oversight-of-the-initiation-of-treatment-for-patients-under-18-years-of-age'}, {'publish_date': NaT, 'title': 'MedSafetyWeek November 2023: your Yellow Card report helps to improve patient safety', 'url': 'https://www.gov.uk/drug-safety-update/medsafetyweek-november-2023-your-yellow-card-report-helps-to-improve-patient-safety'}]\n"
     ]
    }
   ],
   "source": [
    "df = scrape_drug_safety_updates()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "d2c811e4-47a5-4a18-98a1-0cac835a4874",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-07-11T18:34:15.885389Z",
     "iopub.status.busy": "2025-07-11T18:34:15.884844Z",
     "iopub.status.idle": "2025-07-11T18:34:15.896849Z",
     "shell.execute_reply": "2025-07-11T18:34:15.896485Z",
     "shell.execute_reply.started": "2025-07-11T18:34:15.885356Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>publish_date</th>\n",
       "      <th>title</th>\n",
       "      <th>url</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Abrysvo▼ (Pfizer RSV vaccine) and Arexvy▼ (GSK...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/abrysvov...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NaT</td>\n",
       "      <td>IXCHIQ Chikungunya vaccine: temporary suspensi...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/ixchiq-c...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Valproate (Belvo, Convulex, Depakote, Dyzantil...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/valproat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Thiopurines and intrahepatic cholestasis of pr...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/thiopuri...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Kaftrio▼ (Ivacaftor, tezacaftor, elexacaftor):...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/kaftriov...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Short-acting beta 2 agonists (SABA) (salbutamo...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/short-ac...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Fezolinetant▼(Veoza): risk of liver injury; ne...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/fezoline...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Prolonged-release opioids: Removal of indicati...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/prolonge...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Valproate (Belvo, Convulex, Depakote, Dyzantil...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/valproat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>NaT</td>\n",
       "      <td>GLP-1 and dual GIP/GLP-1 receptor agonists: po...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/glp-1-an...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>NaT</td>\n",
       "      <td>MedSafetyWeek November 2024: your Yellow Card ...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/medsafet...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>NaT</td>\n",
       "      <td>GLP-1 receptor agonists: reminder of the poten...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/glp-1-re...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Insulin pumps and continuous glucose monitorin...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/insulin-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Bromocriptine: monitor blood pressure when pre...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/bromocri...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Valproate use in men: as a precaution, men and...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/valproat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Yellow Card Biobank: call to contribute to stu...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/yellow-c...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Epimax Ointment and Epimax Paraffin-Free Ointm...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/epimax-o...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Topiramate (Topamax): introduction of new safe...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/topirama...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Warfarin: be alert to the risk of drug interac...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/warfarin...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Topical steroids: introduction of new labellin...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/topical-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Finasteride: reminder of the risk psychiatric ...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/finaster...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Montelukast: reminder of the risk of neuropsyc...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/monteluk...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Codeine linctus (codeine oral solutions): recl...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/codeine-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Pseudoephedrine: very rare risk of posterior r...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/pseudoep...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Valproate (Belvo, Convulex, Depakote, Dyzantil...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/valproat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Fluoroquinolone antibiotics: must now only be ...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/fluoroqu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Omega-3-acid ethyl ester medicines (Omacor/Ter...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/omega-3-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Aripiprazole (Abilify and generic brands): ris...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/aripipra...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Vitamin B12 (hydroxocobalamin, cyanocobalamin)...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/vitamin-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Ozempic▼(semaglutide) and Saxenda (liraglutide...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/ozempicv...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Nirmatrelvir, ritonavir (Paxlovid▼): be alert ...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/nirmatre...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>NaT</td>\n",
       "      <td>E-cigarette use or vaping: reminder to remain ...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/e-cigare...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Isotretinoin (Roaccutane▼): introduction of ne...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/isotreti...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>NaT</td>\n",
       "      <td>MedSafetyWeek November 2023: your Yellow Card ...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/medsafet...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   publish_date                                              title  \\\n",
       "0           NaT  Abrysvo▼ (Pfizer RSV vaccine) and Arexvy▼ (GSK...   \n",
       "1           NaT  IXCHIQ Chikungunya vaccine: temporary suspensi...   \n",
       "2           NaT  Valproate (Belvo, Convulex, Depakote, Dyzantil...   \n",
       "3           NaT  Thiopurines and intrahepatic cholestasis of pr...   \n",
       "4           NaT  Kaftrio▼ (Ivacaftor, tezacaftor, elexacaftor):...   \n",
       "5           NaT  Short-acting beta 2 agonists (SABA) (salbutamo...   \n",
       "6           NaT  Fezolinetant▼(Veoza): risk of liver injury; ne...   \n",
       "7           NaT  Prolonged-release opioids: Removal of indicati...   \n",
       "8           NaT  Letters and medicine recalls sent to healthcar...   \n",
       "9           NaT  Valproate (Belvo, Convulex, Depakote, Dyzantil...   \n",
       "10          NaT  GLP-1 and dual GIP/GLP-1 receptor agonists: po...   \n",
       "11          NaT  Letters and medicine recalls sent to healthcar...   \n",
       "12          NaT  Letters and medicine recalls sent to healthcar...   \n",
       "13          NaT  MedSafetyWeek November 2024: your Yellow Card ...   \n",
       "14          NaT  Letters and medicine recalls sent to healthcar...   \n",
       "15          NaT  GLP-1 receptor agonists: reminder of the poten...   \n",
       "16          NaT  Insulin pumps and continuous glucose monitorin...   \n",
       "17          NaT  Bromocriptine: monitor blood pressure when pre...   \n",
       "18          NaT  Letters and medicine recalls sent to healthcar...   \n",
       "19          NaT  Letters and medicine recalls sent to healthcar...   \n",
       "20          NaT  Valproate use in men: as a precaution, men and...   \n",
       "21          NaT  Yellow Card Biobank: call to contribute to stu...   \n",
       "22          NaT  Letters and medicine recalls sent to healthcar...   \n",
       "23          NaT  Epimax Ointment and Epimax Paraffin-Free Ointm...   \n",
       "24          NaT  Letters and medicine recalls sent to healthcar...   \n",
       "25          NaT  Topiramate (Topamax): introduction of new safe...   \n",
       "26          NaT  Warfarin: be alert to the risk of drug interac...   \n",
       "27          NaT  Letters and medicine recalls sent to healthcar...   \n",
       "28          NaT  Topical steroids: introduction of new labellin...   \n",
       "29          NaT  Letters and medicine recalls sent to healthcar...   \n",
       "30          NaT  Finasteride: reminder of the risk psychiatric ...   \n",
       "31          NaT  Montelukast: reminder of the risk of neuropsyc...   \n",
       "32          NaT  Letters and medicine recalls sent to healthcar...   \n",
       "33          NaT  Letters and medicine recalls sent to healthcar...   \n",
       "34          NaT  Codeine linctus (codeine oral solutions): recl...   \n",
       "35          NaT  Pseudoephedrine: very rare risk of posterior r...   \n",
       "36          NaT  Letters and medicine recalls sent to healthcar...   \n",
       "37          NaT  Valproate (Belvo, Convulex, Depakote, Dyzantil...   \n",
       "38          NaT  Fluoroquinolone antibiotics: must now only be ...   \n",
       "39          NaT  Omega-3-acid ethyl ester medicines (Omacor/Ter...   \n",
       "40          NaT  Letters and medicine recalls sent to healthcar...   \n",
       "41          NaT  Aripiprazole (Abilify and generic brands): ris...   \n",
       "42          NaT  Vitamin B12 (hydroxocobalamin, cyanocobalamin)...   \n",
       "43          NaT  Letters and medicine recalls sent to healthcar...   \n",
       "44          NaT  Ozempic▼(semaglutide) and Saxenda (liraglutide...   \n",
       "45          NaT  Nirmatrelvir, ritonavir (Paxlovid▼): be alert ...   \n",
       "46          NaT  E-cigarette use or vaping: reminder to remain ...   \n",
       "47          NaT  Letters and medicine recalls sent to healthcar...   \n",
       "48          NaT  Isotretinoin (Roaccutane▼): introduction of ne...   \n",
       "49          NaT  MedSafetyWeek November 2023: your Yellow Card ...   \n",
       "\n",
       "                                                  url  \n",
       "0   https://www.gov.uk/drug-safety-update/abrysvov...  \n",
       "1   https://www.gov.uk/drug-safety-update/ixchiq-c...  \n",
       "2   https://www.gov.uk/drug-safety-update/valproat...  \n",
       "3   https://www.gov.uk/drug-safety-update/thiopuri...  \n",
       "4   https://www.gov.uk/drug-safety-update/kaftriov...  \n",
       "5   https://www.gov.uk/drug-safety-update/short-ac...  \n",
       "6   https://www.gov.uk/drug-safety-update/fezoline...  \n",
       "7   https://www.gov.uk/drug-safety-update/prolonge...  \n",
       "8   https://www.gov.uk/drug-safety-update/letters-...  \n",
       "9   https://www.gov.uk/drug-safety-update/valproat...  \n",
       "10  https://www.gov.uk/drug-safety-update/glp-1-an...  \n",
       "11  https://www.gov.uk/drug-safety-update/letters-...  \n",
       "12  https://www.gov.uk/drug-safety-update/letters-...  \n",
       "13  https://www.gov.uk/drug-safety-update/medsafet...  \n",
       "14  https://www.gov.uk/drug-safety-update/letters-...  \n",
       "15  https://www.gov.uk/drug-safety-update/glp-1-re...  \n",
       "16  https://www.gov.uk/drug-safety-update/insulin-...  \n",
       "17  https://www.gov.uk/drug-safety-update/bromocri...  \n",
       "18  https://www.gov.uk/drug-safety-update/letters-...  \n",
       "19  https://www.gov.uk/drug-safety-update/letters-...  \n",
       "20  https://www.gov.uk/drug-safety-update/valproat...  \n",
       "21  https://www.gov.uk/drug-safety-update/yellow-c...  \n",
       "22  https://www.gov.uk/drug-safety-update/letters-...  \n",
       "23  https://www.gov.uk/drug-safety-update/epimax-o...  \n",
       "24  https://www.gov.uk/drug-safety-update/letters-...  \n",
       "25  https://www.gov.uk/drug-safety-update/topirama...  \n",
       "26  https://www.gov.uk/drug-safety-update/warfarin...  \n",
       "27  https://www.gov.uk/drug-safety-update/letters-...  \n",
       "28  https://www.gov.uk/drug-safety-update/topical-...  \n",
       "29  https://www.gov.uk/drug-safety-update/letters-...  \n",
       "30  https://www.gov.uk/drug-safety-update/finaster...  \n",
       "31  https://www.gov.uk/drug-safety-update/monteluk...  \n",
       "32  https://www.gov.uk/drug-safety-update/letters-...  \n",
       "33  https://www.gov.uk/drug-safety-update/letters-...  \n",
       "34  https://www.gov.uk/drug-safety-update/codeine-...  \n",
       "35  https://www.gov.uk/drug-safety-update/pseudoep...  \n",
       "36  https://www.gov.uk/drug-safety-update/letters-...  \n",
       "37  https://www.gov.uk/drug-safety-update/valproat...  \n",
       "38  https://www.gov.uk/drug-safety-update/fluoroqu...  \n",
       "39  https://www.gov.uk/drug-safety-update/omega-3-...  \n",
       "40  https://www.gov.uk/drug-safety-update/letters-...  \n",
       "41  https://www.gov.uk/drug-safety-update/aripipra...  \n",
       "42  https://www.gov.uk/drug-safety-update/vitamin-...  \n",
       "43  https://www.gov.uk/drug-safety-update/letters-...  \n",
       "44  https://www.gov.uk/drug-safety-update/ozempicv...  \n",
       "45  https://www.gov.uk/drug-safety-update/nirmatre...  \n",
       "46  https://www.gov.uk/drug-safety-update/e-cigare...  \n",
       "47  https://www.gov.uk/drug-safety-update/letters-...  \n",
       "48  https://www.gov.uk/drug-safety-update/isotreti...  \n",
       "49  https://www.gov.uk/drug-safety-update/medsafet...  "
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "7350041a-10e6-44af-af97-fcf5b92797d8",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-07-11T18:35:16.898440Z",
     "iopub.status.busy": "2025-07-11T18:35:16.898104Z",
     "iopub.status.idle": "2025-07-11T18:35:40.104086Z",
     "shell.execute_reply": "2025-07-11T18:35:40.103684Z",
     "shell.execute_reply.started": "2025-07-11T18:35:16.898419Z"
    }
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "  2%|██▋                                                                                                                              | 1/49 [00:23<18:26, 23.05s/it]\n"
     ]
    },
    {
     "ename": "KeyboardInterrupt",
     "evalue": "",
     "output_type": "error",
     "traceback": [
      "\u001b[31m---------------------------------------------------------------------------\u001b[39m",
      "\u001b[31mKeyboardInterrupt\u001b[39m                         Traceback (most recent call last)",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[4]\u001b[39m\u001b[32m, line 12\u001b[39m\n\u001b[32m     10\u001b[39m     markdown_text = scrape_status.markdown\n\u001b[32m     11\u001b[39m     detail.append(markdown_text)\n\u001b[32m---> \u001b[39m\u001b[32m12\u001b[39m     \u001b[43mtime\u001b[49m\u001b[43m.\u001b[49m\u001b[43msleep\u001b[49m\u001b[43m(\u001b[49m\u001b[32;43m10\u001b[39;49m\u001b[43m)\u001b[49m\n\u001b[32m     13\u001b[39m df[\u001b[33m'\u001b[39m\u001b[33mdetail\u001b[39m\u001b[33m'\u001b[39m] = detail\n",
      "\u001b[31mKeyboardInterrupt\u001b[39m: "
     ]
    }
   ],
   "source": [
    "from tqdm import tqdm\n",
    "import time\n",
    "\n",
    "app = FirecrawlApp(api_key=os.getenv('FIRECRAWL_API_KEY'))\n",
    "\n",
    "detail = []\n",
    "for index, row in tqdm(df.iterrows(),total=49):\n",
    "    url = row['url']\n",
    "    scrape_status = app.scrape_url(url, formats=['markdown'])\n",
    "    markdown_text = scrape_status.markdown\n",
    "    detail.append(markdown_text)\n",
    "    time.sleep(10)\n",
    "df['detail'] = detail"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "5df071e3-c4b2-4abf-99a9-c80174be3674",
   "metadata": {},
   "outputs": [],
   "source": [
    "from firecrawl import FirecrawlApp, ScrapeOptions"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "0253176e-ddd5-4f55-8b3a-42fb0f77f71e",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-07-11T17:50:37.824461Z",
     "iopub.status.busy": "2025-07-11T17:50:37.823623Z",
     "iopub.status.idle": "2025-07-11T17:50:37.837201Z",
     "shell.execute_reply": "2025-07-11T17:50:37.836753Z",
     "shell.execute_reply.started": "2025-07-11T17:50:37.824416Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>publish_date</th>\n",
       "      <th>title</th>\n",
       "      <th>url</th>\n",
       "      <th>detail</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Abrysvo▼ (Pfizer RSV vaccine) and Arexvy▼ (GSK...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/abrysvov...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NaT</td>\n",
       "      <td>IXCHIQ Chikungunya vaccine: temporary suspensi...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/ixchiq-c...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Valproate (Belvo, Convulex, Depakote, Dyzantil...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/valproat...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Thiopurines and intrahepatic cholestasis of pr...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/thiopuri...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Kaftrio▼ (Ivacaftor, tezacaftor, elexacaftor):...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/kaftriov...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Short-acting beta 2 agonists (SABA) (salbutamo...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/short-ac...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Fezolinetant▼(Veoza): risk of liver injury; ne...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/fezoline...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Prolonged-release opioids: Removal of indicati...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/prolonge...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Valproate (Belvo, Convulex, Depakote, Dyzantil...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/valproat...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>NaT</td>\n",
       "      <td>GLP-1 and dual GIP/GLP-1 receptor agonists: po...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/glp-1-an...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>NaT</td>\n",
       "      <td>MedSafetyWeek November 2024: your Yellow Card ...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/medsafet...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>NaT</td>\n",
       "      <td>GLP-1 receptor agonists: reminder of the poten...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/glp-1-re...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Insulin pumps and continuous glucose monitorin...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/insulin-...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Bromocriptine: monitor blood pressure when pre...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/bromocri...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Valproate use in men: as a precaution, men and...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/valproat...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Yellow Card Biobank: call to contribute to stu...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/yellow-c...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Epimax Ointment and Epimax Paraffin-Free Ointm...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/epimax-o...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Topiramate (Topamax): introduction of new safe...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/topirama...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Warfarin: be alert to the risk of drug interac...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/warfarin...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Topical steroids: introduction of new labellin...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/topical-...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Finasteride: reminder of the risk psychiatric ...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/finaster...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Montelukast: reminder of the risk of neuropsyc...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/monteluk...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Codeine linctus (codeine oral solutions): recl...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/codeine-...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Pseudoephedrine: very rare risk of posterior r...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/pseudoep...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Valproate (Belvo, Convulex, Depakote, Dyzantil...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/valproat...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Fluoroquinolone antibiotics: must now only be ...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/fluoroqu...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Omega-3-acid ethyl ester medicines (Omacor/Ter...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/omega-3-...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Aripiprazole (Abilify and generic brands): ris...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/aripipra...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Vitamin B12 (hydroxocobalamin, cyanocobalamin)...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/vitamin-...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Ozempic▼(semaglutide) and Saxenda (liraglutide...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/ozempicv...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Nirmatrelvir, ritonavir (Paxlovid▼): be alert ...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/nirmatre...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>NaT</td>\n",
       "      <td>E-cigarette use or vaping: reminder to remain ...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/e-cigare...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Letters and medicine recalls sent to healthcar...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/letters-...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>NaT</td>\n",
       "      <td>Isotretinoin (Roaccutane▼): introduction of ne...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/isotreti...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>NaT</td>\n",
       "      <td>MedSafetyWeek November 2023: your Yellow Card ...</td>\n",
       "      <td>https://www.gov.uk/drug-safety-update/medsafet...</td>\n",
       "      <td>## Cookies on GOV.UK\\n\\nWe use some essential ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   publish_date                                              title  \\\n",
       "0           NaT  Abrysvo▼ (Pfizer RSV vaccine) and Arexvy▼ (GSK...   \n",
       "1           NaT  IXCHIQ Chikungunya vaccine: temporary suspensi...   \n",
       "2           NaT  Valproate (Belvo, Convulex, Depakote, Dyzantil...   \n",
       "3           NaT  Thiopurines and intrahepatic cholestasis of pr...   \n",
       "4           NaT  Kaftrio▼ (Ivacaftor, tezacaftor, elexacaftor):...   \n",
       "5           NaT  Short-acting beta 2 agonists (SABA) (salbutamo...   \n",
       "6           NaT  Fezolinetant▼(Veoza): risk of liver injury; ne...   \n",
       "7           NaT  Prolonged-release opioids: Removal of indicati...   \n",
       "8           NaT  Letters and medicine recalls sent to healthcar...   \n",
       "9           NaT  Valproate (Belvo, Convulex, Depakote, Dyzantil...   \n",
       "10          NaT  GLP-1 and dual GIP/GLP-1 receptor agonists: po...   \n",
       "11          NaT  Letters and medicine recalls sent to healthcar...   \n",
       "12          NaT  Letters and medicine recalls sent to healthcar...   \n",
       "13          NaT  MedSafetyWeek November 2024: your Yellow Card ...   \n",
       "14          NaT  Letters and medicine recalls sent to healthcar...   \n",
       "15          NaT  GLP-1 receptor agonists: reminder of the poten...   \n",
       "16          NaT  Insulin pumps and continuous glucose monitorin...   \n",
       "17          NaT  Bromocriptine: monitor blood pressure when pre...   \n",
       "18          NaT  Letters and medicine recalls sent to healthcar...   \n",
       "19          NaT  Letters and medicine recalls sent to healthcar...   \n",
       "20          NaT  Valproate use in men: as a precaution, men and...   \n",
       "21          NaT  Yellow Card Biobank: call to contribute to stu...   \n",
       "22          NaT  Letters and medicine recalls sent to healthcar...   \n",
       "23          NaT  Epimax Ointment and Epimax Paraffin-Free Ointm...   \n",
       "24          NaT  Letters and medicine recalls sent to healthcar...   \n",
       "25          NaT  Topiramate (Topamax): introduction of new safe...   \n",
       "26          NaT  Warfarin: be alert to the risk of drug interac...   \n",
       "27          NaT  Letters and medicine recalls sent to healthcar...   \n",
       "28          NaT  Topical steroids: introduction of new labellin...   \n",
       "29          NaT  Letters and medicine recalls sent to healthcar...   \n",
       "30          NaT  Finasteride: reminder of the risk psychiatric ...   \n",
       "31          NaT  Montelukast: reminder of the risk of neuropsyc...   \n",
       "32          NaT  Letters and medicine recalls sent to healthcar...   \n",
       "33          NaT  Letters and medicine recalls sent to healthcar...   \n",
       "34          NaT  Codeine linctus (codeine oral solutions): recl...   \n",
       "35          NaT  Pseudoephedrine: very rare risk of posterior r...   \n",
       "36          NaT  Letters and medicine recalls sent to healthcar...   \n",
       "37          NaT  Valproate (Belvo, Convulex, Depakote, Dyzantil...   \n",
       "38          NaT  Fluoroquinolone antibiotics: must now only be ...   \n",
       "39          NaT  Omega-3-acid ethyl ester medicines (Omacor/Ter...   \n",
       "40          NaT  Letters and medicine recalls sent to healthcar...   \n",
       "41          NaT  Aripiprazole (Abilify and generic brands): ris...   \n",
       "42          NaT  Vitamin B12 (hydroxocobalamin, cyanocobalamin)...   \n",
       "43          NaT  Letters and medicine recalls sent to healthcar...   \n",
       "44          NaT  Ozempic▼(semaglutide) and Saxenda (liraglutide...   \n",
       "45          NaT  Nirmatrelvir, ritonavir (Paxlovid▼): be alert ...   \n",
       "46          NaT  E-cigarette use or vaping: reminder to remain ...   \n",
       "47          NaT  Letters and medicine recalls sent to healthcar...   \n",
       "48          NaT  Isotretinoin (Roaccutane▼): introduction of ne...   \n",
       "49          NaT  MedSafetyWeek November 2023: your Yellow Card ...   \n",
       "\n",
       "                                                  url  \\\n",
       "0   https://www.gov.uk/drug-safety-update/abrysvov...   \n",
       "1   https://www.gov.uk/drug-safety-update/ixchiq-c...   \n",
       "2   https://www.gov.uk/drug-safety-update/valproat...   \n",
       "3   https://www.gov.uk/drug-safety-update/thiopuri...   \n",
       "4   https://www.gov.uk/drug-safety-update/kaftriov...   \n",
       "5   https://www.gov.uk/drug-safety-update/short-ac...   \n",
       "6   https://www.gov.uk/drug-safety-update/fezoline...   \n",
       "7   https://www.gov.uk/drug-safety-update/prolonge...   \n",
       "8   https://www.gov.uk/drug-safety-update/letters-...   \n",
       "9   https://www.gov.uk/drug-safety-update/valproat...   \n",
       "10  https://www.gov.uk/drug-safety-update/glp-1-an...   \n",
       "11  https://www.gov.uk/drug-safety-update/letters-...   \n",
       "12  https://www.gov.uk/drug-safety-update/letters-...   \n",
       "13  https://www.gov.uk/drug-safety-update/medsafet...   \n",
       "14  https://www.gov.uk/drug-safety-update/letters-...   \n",
       "15  https://www.gov.uk/drug-safety-update/glp-1-re...   \n",
       "16  https://www.gov.uk/drug-safety-update/insulin-...   \n",
       "17  https://www.gov.uk/drug-safety-update/bromocri...   \n",
       "18  https://www.gov.uk/drug-safety-update/letters-...   \n",
       "19  https://www.gov.uk/drug-safety-update/letters-...   \n",
       "20  https://www.gov.uk/drug-safety-update/valproat...   \n",
       "21  https://www.gov.uk/drug-safety-update/yellow-c...   \n",
       "22  https://www.gov.uk/drug-safety-update/letters-...   \n",
       "23  https://www.gov.uk/drug-safety-update/epimax-o...   \n",
       "24  https://www.gov.uk/drug-safety-update/letters-...   \n",
       "25  https://www.gov.uk/drug-safety-update/topirama...   \n",
       "26  https://www.gov.uk/drug-safety-update/warfarin...   \n",
       "27  https://www.gov.uk/drug-safety-update/letters-...   \n",
       "28  https://www.gov.uk/drug-safety-update/topical-...   \n",
       "29  https://www.gov.uk/drug-safety-update/letters-...   \n",
       "30  https://www.gov.uk/drug-safety-update/finaster...   \n",
       "31  https://www.gov.uk/drug-safety-update/monteluk...   \n",
       "32  https://www.gov.uk/drug-safety-update/letters-...   \n",
       "33  https://www.gov.uk/drug-safety-update/letters-...   \n",
       "34  https://www.gov.uk/drug-safety-update/codeine-...   \n",
       "35  https://www.gov.uk/drug-safety-update/pseudoep...   \n",
       "36  https://www.gov.uk/drug-safety-update/letters-...   \n",
       "37  https://www.gov.uk/drug-safety-update/valproat...   \n",
       "38  https://www.gov.uk/drug-safety-update/fluoroqu...   \n",
       "39  https://www.gov.uk/drug-safety-update/omega-3-...   \n",
       "40  https://www.gov.uk/drug-safety-update/letters-...   \n",
       "41  https://www.gov.uk/drug-safety-update/aripipra...   \n",
       "42  https://www.gov.uk/drug-safety-update/vitamin-...   \n",
       "43  https://www.gov.uk/drug-safety-update/letters-...   \n",
       "44  https://www.gov.uk/drug-safety-update/ozempicv...   \n",
       "45  https://www.gov.uk/drug-safety-update/nirmatre...   \n",
       "46  https://www.gov.uk/drug-safety-update/e-cigare...   \n",
       "47  https://www.gov.uk/drug-safety-update/letters-...   \n",
       "48  https://www.gov.uk/drug-safety-update/isotreti...   \n",
       "49  https://www.gov.uk/drug-safety-update/medsafet...   \n",
       "\n",
       "                                               detail  \n",
       "0   ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "1   ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "2   ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "3   ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "4   ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "5   ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "6   ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "7   ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "8   ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "9   ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "10  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "11  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "12  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "13  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "14  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "15  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "16  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "17  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "18  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "19  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "20  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "21  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "22  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "23  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "24  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "25  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "26  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "27  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "28  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "29  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "30  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "31  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "32  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "33  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "34  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "35  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "36  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "37  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "38  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "39  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "40  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "41  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "42  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "43  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "44  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "45  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "46  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "47  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "48  ## Cookies on GOV.UK\\n\\nWe use some essential ...  \n",
       "49  ## Cookies on GOV.UK\\n\\nWe use some essential ...  "
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "79ee24b4-3250-4893-98f1-16036cb07d86",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-07-11T17:52:19.906156Z",
     "iopub.status.busy": "2025-07-11T17:52:19.905816Z",
     "iopub.status.idle": "2025-07-11T17:52:19.924282Z",
     "shell.execute_reply": "2025-07-11T17:52:19.923451Z",
     "shell.execute_reply.started": "2025-07-11T17:52:19.906137Z"
    }
   },
   "outputs": [],
   "source": [
    "df.to_csv('data.csv', index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "c19aa26b-3dda-443b-84e4-2e655a7a01b6",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "39a65987-0de0-415d-8814-e9c526d9f10a",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "efdf0b1d-79ec-485c-89f2-f1cc8e11c9a0",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "cd3765d9-a231-439b-a9dd-10abbce520b4",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "a579eaaa-57f9-43c0-906c-1be6c33f60bd",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "587ae1c6-4b17-4bad-8162-3e2f0e4cec89",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.9"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
